---
title: "National Healthcare Security Administration: Key drug \"Deferasirox\" for treating \"thalassemia\" included in medical insurance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274372521.md"
description: "On January 31, according to the National Healthcare Security Administration, the new national medical insurance drug list will be fully implemented in Guangxi starting from January 1, 2026. In this adjustment of the list, the National Healthcare Security Administration has included \"Deferasirox Tablets\" in the national medical insurance drug list through negotiations, effectively addressing the medical needs of patients with thalassemia and reducing the medication burden on insured patients' families. Before being included in medical insurance, urban and rural residents' patients incurred nearly 3,000 yuan in out-of-pocket expenses per month for treatment at designated institutions in cities and counties. After being included in medical insurance, the negotiated price reduction combined with medical insurance reimbursement means that individuals only need to pay one-tenth of the original amount"
datetime: "2026-01-31T02:39:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274372521.md)
  - [en](https://longbridge.com/en/news/274372521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274372521.md)
---

# National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance

On January 31, according to the National Healthcare Security Administration, the new national medical insurance drug list will be fully implemented in Guangxi starting from January 1, 2026. In this adjustment of the list, the National Healthcare Security Administration has included "Deferasirox Tablets" in the national medical insurance drug list through negotiations, effectively addressing the medical needs of patients with thalassemia and reducing the medication burden on insured patients' families. Before being included in medical insurance, urban and rural residents' patients incurred nearly 3,000 yuan in monthly out-of-pocket expenses at designated medical institutions in cities and counties. After being included in medical insurance, the negotiated price reduction combined with medical insurance reimbursement means that individuals only need to pay one-tenth of the original amount

### Related Stocks

- [002038.CN](https://longbridge.com/en/quote/002038.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [000963.CN](https://longbridge.com/en/quote/000963.CN.md)
- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [603367.CN](https://longbridge.com/en/quote/603367.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [600521.CN](https://longbridge.com/en/quote/600521.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [002950.CN](https://longbridge.com/en/quote/002950.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds](https://longbridge.com/en/news/286487023.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)